Clinical Trials
31. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine.
- Author
- Hershey AD; Powers SW; Vockell AL; Lecates SL; Ellinor PL; Segers A; Burdine D; Manning P; Kabbouche MA;
- Institution
- Division of Neurology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
- Journal
- Headache. 2007 Jan;47(1):73-80.
- Abstract URL
- Click here to view abstract
32. Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.
- Author
- Lainez MJ; Galvan J; Heras J; Vila C;
- Institution
- Neurology Department, Hospital Clinic Universitari, University of Valencia, Valencia, Spain. jlaineza@meditex.es
- Journal
- Eur J Neurol. 2007 Mar;14(3):269-75.
- Abstract URL
- Click here to view abstract
33. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
- Author
- Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
- Institution
- Jefferson Headache Center, Philadelphia, PA 19107, USA.
- Journal
- Headache. 2007 Feb;47(2):170-80.
- Abstract URL
- Click here to view abstract
34. Almotriptan and zolmitriptan in the acute treatment of migraine.
- Author
- Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlof CG; Mateos V; Dowson AJ; Raets I; Cunha L; Farkkila M; Manzoni GC;
- Institution
- Headache Group, Institute of Neurology, Queen Square, London, UK. peterg@ion.ucl.ac.uk
- Journal
- Acta Neurol Scand. 2007 Jan;115(1):34-40.
- Abstract URL
- Click here to view abstract
35. Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study.
- Author
- Diener HC; Evers S;
- Institution
- Department of Neurology, University of Duisburg-Essen, Essen, Germany. hans.diener@uni-duisburg-essen.de
- Journal
- Clin Drug Investig. 2007;27(1):59-66.
- Abstract URL
- Click here to view abstract
36. Testing the combination beta-blocker plus topiramate in refractory migraine.
- Author
- Pascual J; Rivas MT; Leira R;
- Institution
- Service of Neurology, University Hospital, Salamanca, Spain. juliopascual@telefonica.net
- Journal
- Acta Neurol Scand. 2007 Feb;115(2):81-3.
- Abstract URL
- Click here to view abstract
37. Diclofenac epolamine is effective in the treatment of acute migraine attacks. A randomized, crossover, double blind, placebo-controlled, clinical study.
- Author
- Vecsei L; Gallacchi G; Sagi I; Semjen J; Tajti J; Szok D; Muller M; Vadass P; Kerekgyarto M;
- Institution
- Department of Neurology, Albert Szent-Gyorgyi Medical and Pharmaceutical Centre, University of Szeged and Neurology Research Group of the Hungarian Academy of Sciences and University of Szeged, Szeged, Hungary. giuseppe.mautone@ibsa.ch
- Journal
- Cephalalgia. 2007 Jan;27(1):29-34.
- Abstract URL
- Click here to view abstract
38. Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptans.
- Author
- Diamond S; Freitag FG; Feoktistov A; Nissan G;
- Institution
- Diamond Headache Clinic, 467 West Deming Place, Suite 500, Chicago, IL 60614, USA. MACF48@aol.com
- Journal
- J Headache Pain. 2007 Feb;8(1):13-8. Epub 2007 Jan 15.
- Abstract URL
- Click here to view abstract
39. How many migraine patients need prolonged (>1 year) preventive treatment? Experience with topiramate.
- Author
- Pascual J; El Berdei Y; Gomez-Sanchez JC;
- Institution
- Service of Neurology, University Hospital, Paseo de San Vicente 58-132, 37007, Salamanca, Spain. juliopascual@telefonica.net
- Journal
- J Headache Pain. 2007 Apr;8(2):90-3. Epub 2007 Jan 15.
- Abstract URL
- Click here to view abstract
40. Effectiveness of ropivacaine trigger points inactivation in the prophylactic management of patients with severe migraine.
- Author
- Garcia-Leiva JM; Hidalgo J; Rico-Villademoros F; Moreno V; Calandre EP;
- Institution
- Instituto de Neurociencias, Universidad de Granada, Granada, Spain.
- Journal
- Pain Med. 2007 Jan-Feb;8(1):65-70.
- Abstract URL
- Click here to view abstract
Previous Section
